Project Description

Browne McGregor Architects provided master planning, programming and full architectural services for a 30,000 square foot, two story Research & Administration Building and a 12,000 square foot, single story Production Facility for Introgen Therapeutics for the research and development, and production of gene therapy medicines for use in late stage clinical trials.